SGK1 and prostate carcinoma: As an inhibitor of serum- and glucocorticoid-regulated kinases (SGK)28, GSK650394 has been shown to inhibit the proliferation of various human cancer cells, such as lung cancer29, thyroid cancer30, and human prostate cancer.28